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Abstract
Purpose:  The  goal  of  this  study  is  to  investigate  whether  combined  application  of  ultrasound
and 99mTc-sestamibi  SPECT/CT  had  the  incremental  value  in  accurately  detecting  parathyroid
tissue in  patients  with  SHPT  over  either  method  alone.
Patients  and  methods:  Sixty  patients  with  SHPT  on  hemodialysis  were  evaluated  preoperatively
with parathyroid  99mTc-sestamibi  SPECT/CT  scintigraphy  and  ultrasound  prior  to  parathy-
roidectomy.  The  sensitivity,  speciﬁcity  and  accuracy  of  99mTc-sestamibi  SPECT/CT  scintigraphy,
ultrasound  and  combined  application  were  determined  respectively.
Results:  The  sensitivity,  speciﬁcity  and  accuracy  of  ultrasound  were  81%  (155/192),  47%  (17/36)
and 82%  (172/228),  respectively.  The  sensitivity,  speciﬁcity  and  accuracy  of  99mTc-sestamibi
SPECT/CT  were  85%  (163/192),  58%  (21/36)  and  89%  (184/228)  respectively.  The  accuracy  of
99mTc-sestamibi  SPECT/CT  in  the  diagnosis  of  parathyroid  tissue  in  patients  with  SHPT  is  sig-
niﬁcantly  higher  than  that  of  ultrasound.  The  sensitivity,  speciﬁcity  and  accuracy  of  combined
application  of  ultrasound  and  99mTc-sestamibi  SPECT/CT  were  93%  (178/192),  61%  (22/36)  and
ity,  speciﬁcity  and  accuracy  of  combined  application  of  ultrasound97% (200/228).  The  sensitiv
and 99mTc-sestamibi  SPECT/CT  were  higher  than  those  of  either  ultrasound  or  99mTc-sestamibi
SPECT/CT.
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Conclusions:  The  combined  application  of  ultrasound  and  99mTc-sestamibi  SPECT/CT  had  incre-
mental value  in  accurately  detecting  parathyroid  tissue  in  patients  with  SHPT  over  either
method  alone.
©  2015  Éditions  franc¸aises  de  radiologie.  Published  by  Elsevier  Masson  SAS.  All  rights  reserved.
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Iecondary  hyperparathyroidism  (SHPT)  is  a  common  and
ajor  complication  of  patients  with  end  stage  renal  dis-
ase  (ESRD)  [1].  Current  medicine  interventions  in  treating
HPT  have  the  potential  to  improve  biochemical  proﬁles
nd  other  surrogate  markers  [2].  However,  some  patients
ould  present  resistance  to  these  medicines.  Uncontrolled
HPT  is  associated  with  an  increased  risk  of  fractures  and
ortality.  Parathyroidectomy  (PTX)  is  reserved  for  medi-
ally  refractory  and  severe  SHPT.  PTX  increases  long-term
urvival  in  ESRD  patients,  decreases  the  risk  of  fracture
3].  However,  the  rate  of  persistent  and  recurrent  disease
fter  parathyroidectomy  is  ranged  between  10%  and  30%
4].  The  principal  cause  of  surgical  failure  still  remains  the
ncomplete  intraoperative  identiﬁcation  and  excision  of  all
yperplasic  parathyroid  glands  [5].  Therefore,  it  is  very
mportant  to  correctly  locate  all  parathyroid  tissues  preop-
ratively.
Different  imaging  methods  have  been  used  in  the  pre-
perative  localization  of  parathyroid  tissue.  However,  it  is
till  an  argument  of  which  diagnostic  method  is  the  best
o  preoperatively  localize  parathyroid  tissue  in  patients
ith  SHPT,  including  ultrasound,  99mTc-sestamibi  scintigra-
hy,  intraoperative  quick  intact  parathyroid  hormone  (iPTH)
ssay  [6].  Accurate  localization  of  abnormal  parathyroid
land,  especially  ectopic  parathyroid,  may  be  very  useful
o  guide  the  surgery,  especially  in  high-risk  patients.  Pre-
ious  studies  have  investigated  the  role  of  ultrasound  and
9mTc-sestamibi  parathyroid  scan  in  the  diagnosis  of  hyper-
arathyroidism  [7,8].  However,  these  studies  investigated
he  role  of  planar  image,  or  dual  phase  planar  scintigra-
hy,  or  dual  tracer  planar  parathyroid  scintigraphy  combined
ith  ultrasound,  did  not  investigate  the  role  of  parathyroid
PECT/CT  tomographic  scintigraphy  combined  with  ultra-
ound  in  SHPT.  The  goal  of  this  study  is  to  investigate
hether  combined  application  of  ultrasound  and  99mTc-
estamibi  SPECT/CT  had  the  incremental  value  in  accurately
etecting  parathyroid  tissue  in  patients  with  SHPT  over
ither  method  alone.
aterials and methods
atients
he  study  population  included  60  consecutive  ESRD  patients
etween  January  2011  and  December  2014  on  hemodialysis
ho  underwent  preoperative  evaluation  with  99mTc-
estamibi  SPECT/CT  scintigraphy  and  ultrasound  prior  to
arathyroidectomy  for  SHPT  at  our  hospital.  Thirty-nine
d
t
o
tatients  were  female,  21  patients  were  male.  The  average
ge  was  68.1  ±  8.  years  old.  The  mean  PTH  concentration
as  greater  than  600  pg/mL  and  calcium  concentration  was
reater  than  10.4  mg/dL.  Preoperatively,  all  patients  under-
ent  dual  phase  99mTc-sestamibi  SPECT/CT  scintigraphy
nd  ultrasound.  Our  institutional  review  board  provided
pproval  for  the  procedures  of  this  study.
ual phase 99mTc-sestamibi scintigraphy with
PECT/CT
atients  were  injected  intravenously  with  740  MBq  (range,
18—763  MBq)  of  99mTc-sestamibi.  The  image  acquisitions
ere  performed  on  a  dual  head  gamma  camera  equipped
ith  5/8  inch  NaI  crystals  and  multidetector  (4  row)  spi-
al  CT  (Symbia  T2;  Siemens  Medical  Solutions).  Early  phase
PECT/CT  and  delayed  phase  SPECT  images  of  the  neck  were
btained  at  15  and  120  minutes  after  injection,  respectively.
he  image  acquisition  method  is  same  with  the  previous
tudies  [9,10].  At  delayed  SPECT/CT  phase,  only  SPECT  data
as  acquired  for  SPECT/CT.  CT  acquisition  data  of  early
hase  can  be  used  for  delayed  phase  SPECT/CT.
The  interpretation  of  99mTc-sestamibi  scintigraphy  was
erformed  in  consensus  by  2  experienced  nuclear  medicine
hysicians.  The  image  ﬁndings  were  classiﬁed  as  positive  or
egative.  If  the  images  showed  persistent  high  tracer  thy-
oid  uptake  at  delayed  phase,  the  physician  would  attach
ore  attention  to  the  CT  images.  A  scintigraphy  was  recog-
ized  as  positive  if  there  was  a  deﬁnite  focus  of  increased  or
eparate  99mTc-sestamibi  uptake  relative  to  the  uptake  in
he  thyroid  tissue  of  neck  or  mediastinum  on  either  early  or
elayed  SPECT/CT  images.  Precise  location  of  each  focus
as  also  reported.  Scintigraphy  was  negative  when  focal
ptake  in  the  neck  or  mediastinum  was  absent  on  both  early
nd  delayed  phase  SPECT/CT  studies.  Agreement  between
he  two  physicians  was  achieved  in  all  patients  [11].
ltrasound
he  patient  was  examined  in  a  supine  position  with  the
eck  hyperextended.  Ultrasound  was  performed  using  linear
ransducers  (7  to  12  MHz)  for  cervical  examination  in  a  ﬁeld
xtending  from  the  angles  of  the  mandible  to  the  sternum
otch.  Transversal  and  longitudinal  views  were  obtained.
mages  of  regions  of  interest  were  recorded  on  ﬁlm  repro-
ucing  video  images.  The  radiologist  interpreted  each  study
ogether  with  the  surgeon,  because  some  patients  had  previ-
us  operations,  such  as  parathyroid  radiofrequency  ablation,
hyroidectomy,  which  may  inﬂuence  the  result  of  these  scans
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SPECT/CT  scan  demonstrated  12  ectopic  PTGs  (Fig.  1),  while
ultrasound  demonstrated  only  2  intra-thyroid  ectopic  PTGs.
The  other  ectopic  PTGs  were  not  demonstrated  on  ultra-
sound  images.
Table  1  TP,  FP,  FN,  TN  of  ultrasound,  99mTc-
sestamibi  SPECT/CT,  and  combined  ultrasound  and
99mTc-sestamibi  SPECT/CT.
TP  FP  FN  TN
Ultrasound  155  19  37  17Combined  application  of  ultrasound  and  SPECT/CT  
due  to  distortion  and  scarring.  Both  were  unaware  of  results
of  99mTc-sestamibi  scintigraphy.  The  radiologist  was  asked
to  score  the  presence  of  a  hyperplastic  parathyroid  gland
for  each  possible  location  (superior  and  inferior  glands,  on
the  right  and  left  sides).  The  size  of  each  gland  (largest  mea-
surement)  was  measured.  Equivocal  images  were  considered
negative.
Combined application of 99mTc-sestamibi and
ultrasound
True  positive  of  combined  application  of  99mTc-sestamibi
and  ultrasound  was  deﬁned  as  positive  result  by  99mTc-
sestamibi  or  ultrasound.  True  negative  of  combined
application  of  99mTc-sestamibi  and  ultrasound  was  deﬁned
as  negative  result  by  99mTc-sestamibi  and  ultrasound.
Surgical procedures
Subtotal  parathyroidectomy  (sPTX)  and/or  total  parathy-
roidectomy  (tPTX)  with  implant  were  performed  in  young
patients  or  candidates  for  kidney  transplantation  [12].  tPTX
was  performed  in  elder  patients  without  autotransplant.  The
surgeon  referred  to  the  99mTc-sestamibi  scintigraphy  and
ultrasound  results  during  preoperative  planning.  The  sPTX
included  the  ablation  of  3  glands  and  half  of  the  fourth  gland.
Half  of  the  gland  with  most  normal  appearance  was  left  in
situ.  The  choice  of  the  half  gland  with  the  lowest  chance
of  recurrence  was  based  on  size  criteria,  vascularization,
appearance,  and  when  possible,  absent  99mTc-sestamibi
uptake.  The  excised  glands  were  sent  for  frozen  sections.
The  parathyroid  gland  hyperplasia  was  classiﬁed  as  either
diffuse  hyperplasia  or  nodular  hyperplasia  and  based  on  the
histology.
Statistical analysis
All  statistical  tests  were  performed  by  using  SPSS  20.0
software  (SPSS.  Inc.,  Chicago,  IL,  USA).  Comparisons
of  ultrasound  and  pathology,  99mTc-sestamibi  SPECT/CT
scintigraphy  and  pathology  in  the  detection  of  parathyroid
were  performed  using  the  McNemar’s  test,  a  nonparametric
method  for  comparing  paired  dichotomous  data.  A  two-
tailed  P  value  of  0.05  was  considered  to  indicate  statistical
signiﬁcance.
Results
Operation results
Assuming  four  parathyroid  glands  (PTGs)  per  patient,  there
should  have  been  a  total  of  236  PTGs  in  60  patients.  In
our  series,  228  PTGs  were  identiﬁed  and  surgically  resected
in  the  60  patients.  Thirteen  patients  of  sixty  patients
had  5  PTGs.  Twelve  ectopic  PTGs  were  found  in  these
patients  (7  ectopic  PTGs  located  in  mediastinum,  3  located
intra-thyroid,  2 located  in  supernumerary  retro-esophageal
ectopic  glands).  Thirty-two  patients  had  4  PTGs,  eight
patients  had  3  PTGs,  four  patients  had  2  PTGs,  three  patients
had  one  PTG.  In  all  the  60  patients,  9  patients  (16  PTGs)221
reviously  underwent  parathyroid  radiofrequency  abla-
ion,  2  patients  previously  undergone  hemi-thyroidectomy
nd  hemi-parathyroidectomy.  At  pathological  examinations,
6  PTGs  (15.8%)  showed  normal  parathyroid  tissue,  while
92  PTGs  (84.2%)  showed  abnormal  parathyroid  tissue,
ncluding  49  PTGs  (25.5%)  with  diffuse  hyperplasia  and
43  PTGs  (74.5%)  with  nodular  hyperplasia.
ltrasound and 99mTc-sestamibi SPECT/CT
cintigraphy results
he  true  positive,  false  positive,  negative,  true  nega-
ive  cases  of  ultrasound,  99mTc-sestamibi  SPECT/CT,  and
ombined  application  of  ultrasound  and  99mTc-sestamibi
PECT/CT  were  shown  in  Table  1. The  sensitivity,  speci-
city  and  accuracy  of  ultrasound  were  determined  to  be
1%  (155/192),  47%  (17/36)  and  82%  (172/228)  respec-
ively.  At  the  same  time,  ultrasound  showed  thyroid  disease
including  goiter,  adenoma,  carcinoma)  in  57%  (34/60)
atients.  Based  on  the  pathological  result,  15  parathyroid
lands  were  false  positive  results,  which  were  caused
y  thyroid  diseases,  including  6  thyroid  nodule,  3  thyroid
arcinoma,  2  parathyroid  carcinoma,  2  inﬂammatory  lymph
odes,  2  skeletal  brown  tumor.  These  false  positive  results
f  99mTc-sestamibi  SPECT/CT  may  cause  the  failure  of
his  operation.  We  would  follow-up  these  patients  in
he  future.  Concomitant  thyroid  nodularity  may  inﬂu-
nce  the  diagnostic  role  of  these  imaging  methods.  In
he  present  study,  concomitant  thyroid  disease  was  found
n  57%  (34/60)  patients,  which  was  similar  to  previous
tudy  [13]. In  all  163  parathyroid  glands  of  99mTc-MIBI
PECT/CT  scan,  136  parathyroid  glands  were  positive  in
arly  phase,  while  142  parathyroid  glands  were  positive
n  delayed  phase.  The  sensitivity,  speciﬁcity  and  accu-
acy  of  99mTc-sestamibi  SPECT/CT  were  85%  (163/192),
8%  (21/36)  and  89%  (184/228),  respectively.  The  sensi-
ivity,  speciﬁcity  and  accuracy  of  combined  application
f  ultrasound  and  99mTc-sestamibi  SPECT/CT  were  93%
178/192),  61%  (22/36)  and  97%  (200/228),  respectively
Table  2).  In  our  study  population,  thirteen  patients  of
ixty  patients  had  5  PTGs.  Twelve  ectopic  PTGs  were  found
n  these  patients  (7  ectopic  PTGs  located  in  mediastinum,
 located  intra-thyroid,  2  located  in  supernumerary  retro-
sophageal  ectopic  glands).  99mTc-sestamibi  parathyroidSPECT/CT  163  15  29  21
Combination  application 178  14  14  22
TP: true positive; FP: false positive; FN: false negative patients;
TN: true negative.
222  
Table  2  Sensitivity,  speciﬁcity,  accuracy  of  ultrasound,
99mTc-sestamibi  SPECT/CT,  and  combined  ultrasound
and  99mTc-sestamibi  SPECT/CT.
Sensitivity  Speciﬁcity  Accuracy
Ultrasound  0.81  0.47  0.82
SPECT/CT  0.85  0.58  0.89
Combination
application
0.93  0.61  0.97
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respectively.  The  present  study  also  demonstrated  a  discrep-
ancy  between  ultrasound  and  99mTc-sestamibi  SPECT/CT.
F
c
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liscussion
HPT  is  a  frequent  major  complication  for  patients  with
SRD  on  long-term  dialysis.  Patients  with  severe  SHPT  and
atients  with  SHPT  that  is  resistant  to  medical  treatment
hould  undergo  PTX  [14].  In  the  present  study,  all  patients
erformed  sPTX  and/or  tPTX,  which  may  relate  with  the
rue  negative  of  ultrasound,  99mTc-sestamibi  SPECT/CT,  and
ombined  application  of  ultrasound  and  99mTc-sestamibi
PECT/CT.  PTX  usually  improves  biological  parameters  as
ell  as  clinical  signs  and  symptoms  [15].  However,  surgi-
al  results  for  uremic  SHPT  are  less  satisfactory  than  those
n  primary  hyperparathyroidism  with  the  rates  of  persis-
ent  and  recurrent  disease  being  higher  (10%—30%)  [16].
he  main  cause  of  surgical  failure  is  missed  orthotopic
r  ectopic  glands,  too  large  remnant/grafts,  or  supernu-
erary  macroscopic  parathyroid  glands  [17].  CT,  magneticesonance  imaging  (MRI),  arteriography,  and  high-resolution
ltrasound  have  all  been  used  in  the  diagnosis  of  SHPT  [17].
T
i
igure 1. A 62-year-old woman with history of chronic kidney disease t
alcium (21.3 mg/dL) and parathyroid hormone (712 pg/mL) concentrati
left lower), sagittal CT (middle), coronal CT (right) images from 99mTc
eft upper superior mediastinum. Surgical pathologic result was diffuse pL.L.  Yuan  et  al.
owever,  the  performance  of  single  anatomical  technique  is
ot  very  satisfactory  in  SHPT.
The  present  study  showed  that  the  combined  application
f  ultrasound  and  99mTc-sestamibi  parathyroid  SPECT/CT
cintigraphy  for  the  preoperative  localization  of  parathy-
oid  glands  in  SHPT  had  a  higher  sensitivity,  speciﬁcity,
nd  accuracy  than  those  of  ultrasound  or  99mTc-sestamibi
arathyroid  SPECT/CT  scintigraphy  alone.  The  sensitivity,
peciﬁcity  and  accuracy  of  combined  application  of  ultra-
ound  and  99mTc-sestamibi  SPECT/CT  was  93%,  61%  and  97%.
urthermore,  the  combined  application  of  these  imaging
echniques  is  particularly  useful  and  complementary  in  the
lanning  of  the  surgical  strategy  of  uremic  SHPT.  The  sensi-
ivity,  speciﬁcity  and  accuracy  of  ultrasound  in  this  study
ere  determined  to  be  81%,  47%  and  82%,  respectively.
ltrasound  is  largely  used  in  clinical  practice  as  it  is  non-
nvasive,  easily  repeatable  and  has  acceptable  sensitivity
nd  speciﬁcity  (45%—80%  in  SHPT)  [18]. Anari  et  al.  demon-
trated  the  sensitivity,  speciﬁcity,  positive  predictive  value,
nd  negative  predictive  value  of  ultrasound  for  diagnosis  of
nlarged  parathyroid  gland  was  62.5%,  85.7%,  87.5%,  58.8%
19]. Vulpio  et  al.  also  reported  that  ultrasound  parame-
ers  (such  as  maximum  longitudinal  diameter,  structural  and
ascular  echo-pattern  scores)  of  PTGs,  correlated  to  the
egree  of  SHPT  and  type  of  hyperplasia,  could  be  used  to
redict  responsiveness  to  medical  therapy  [18].  The  sensi-
ivity,  speciﬁcity  and  accuracy  of  99mTc-sestamibi  SPECT/CT
f  this  study  were  determined  to  be  85%,  58%  and  89%,he  accuracy  of  99mTc-sestamibi  SPECT/CT  of  this  study
s  signiﬁcantly  higher  than  that  of  ultrasound  (P  <  0.05).
reated with hemodialysis. Laboratory tests showed increased serum
ons. Delayed phase of transaxial SPECT (left upper), transaxial CT
-sestamibi scan showed abnormal radioactive accumulation in the
arathyroid hyperplasia tissue.
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aCombined  application  of  ultrasound  and  SPECT/CT  
Previous  study  reported  the  possible  reason  for  the  lower
sensitivity  of  ultrasound  was  a  relatively  large  number  of
different  operators/reporters  (invariably  with  different  lev-
els  of  experience)  involved  in  parathyroid  ultrasound,  which
would  result  in  greater  interobserver  variability  [20].  On  the
other  hand,  Vulpio  et  al.  reported  that  the  percentage  of
PTGs  visualized  by  ultrasound  was  higher  for  superior  than
that  for  inferior  PTG.  The  possible  cause  may  be  that  the
superior  PTGs  are  usually  localized  at  the  level  of  the  thyro-
laryngeal  groove,  which  can  be  explored  easily  by  ultrasound
[6].  Some  authors  pointed  out  that  the  PTG  site  (superior  or
inferior,  typical  or  ectopic),  the  diameter,  and  the  type  of
hyperplasia  are  the  main  factors  determining  the  ultrasound
patterns  [6].  The  other  possible  reason  of  lower  sensitivity
was  the  overall  risk  that  at  least  one  gland  be  ectopic  in
patients  with  SHPT  was  4  times  higher  [21].  The  sensitivity
of  detecting  ectopic  PTGs  by  ultrasound  is  relative  low  [22].
Previous  studies  investigated  the  role  of  ultrasound  and
99mTc-sestamibi  parathyroid  scan  in  the  diagnosis  of  SHPT.
Vulpio  et  al.  reported  the  usefulness  of  the  combined  ultra-
sound  and  99mTc-sestamibi  scintigraphy  in  the  preoperative
evaluation  of  uremic  SHPT.  This  study  reported  that  the
sensitivity  of  99mTc-sestamibi  scintigraphy  was  62%  [6].
However,  the  sensitivity  of  99mTc-sestamibi  parathyroid
SPECT/CT  scan  of  the  present  study  was  85%,  which  was
signiﬁcantly  higher  than  previous  study.  The  main  cause
was  that  the  99mTc-sestamibi  parathyroid  scan  is  planar
scan  in  previous  study  [6],  not  the  SPECT/CT  tomographic
scan  as  the  present  study.  The  other  cause  included  that
the  mean  PTH  concentration  was  greater  than  600  pg/mL
and  calcium  concentration  was  greater  than  10.4  mg/dL.
Mshelia  et  al.  reported  that  99mTc-MIBI  parathyroid  scintig-
raphy  was  most  likely  to  yield  identiﬁcation  and  localization
of  a  parathyroid  adenoma  when  both  parathyroid  hor-
mone  (PTH)  concentration  and  calcium  are  elevated  [23].
In  the  present  study,  29  PTGs  showed  false  negative  result
in  99mTc-sestamibi  SPECT/CT  scan.  Patients  with  negative
ultrasound  and  scintigraphy  results  had  smaller  parathyroid
lesions  [24].  The  speciﬁcity  of  99mTc-sestamibi  SPECT/CT
scan  in  the  diagnosis  PTG  in  patients  with  SHPT  is  58%.
Previous  study  reported  that  differentiating  thyroid  nod-
ules  from  parathyroid  lesions  in  parathyroid  scintigraphy
was  often  difﬁcult  because  of  the  potential  for  abnor-
mal  tracer  retention  in  thyroid  nodules.  The  most  common
cause  of  false  positive  results  is  the  presence  of  thy-
roid  nodules  [25].  Subtraction  method,  late  99mTc-MIBI
delayed  acquisitions  (2—3  h),  and  SPECT/CT  images  can
all  improve  speciﬁcity.  Thymoma,  metastatic  or  inﬂamma-
tory  lymph  nodes,  and  skeletal  brown  tumors  may  also
represent  rare  potential  false  positive  lesions  [26].  In  the
present  study,  15  parathyroid  glands  were  false  positive
results  in  the  99mTc-sestamibi  SPECT/CT,  including  thyroid
nodule,  thyroid  carcinoma,  parathyroid  carcinoma,  inﬂam-
matory  lymph  nodes,  skeletal  brown  tumor.  These  false
positive  results  of  99mTc-sestamibi  SPECT/CT  may  cause
the  failure  of  this  operation.  SPECT  may  also  reclassify
apparently  inferior  adenomas  (on  planar  images)  to  supe-
rior,  fourth  pharyngeal  pouch-derived  adenomas  prolapsed
behind  the  lower  pole  of  the  thyroid  gland.  These  adenomas
can  be  located  very  deeply  in  the  neck,  in  paraesophageal
or  retroesophageal  locations,  and  may  be  missed  by  neck
ultrasound  [27].
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At  the  present  study,  all  patients  performed  the  dual
hase  99mTc-sestamibi  parathyroid  SPECT/CT  scan.  The
ual  phase  planar  scintigraphy  method  utilizing  99mTc-
estamibi  has  been  widely  employed  in  parathyroid
cintigraphy.  The  dual  phase  planar  scintigraphy  technique
s  easy  to  perform,  easy  to  interpret,  economical  and  has
een  shown  to  provide  high  sensitivity  and  speciﬁcity  in
atients  with  primary  hyperparathyroidism  [28].  Previous
tudies  reported  that  the  sensitivity  of  99mTc-sestamibi  is
ow  in  patients  with  SHPT,  ranging  from  34%  to  66%  [29].  The
resent  study  demonstrated  the  sensitivity,  speciﬁcity  and
ccuracy  of  99mTc-sestamibi  SPECT/CT  was  85%,  58%  and
9%,  respectively.  Zhen  et  al.  have  reported  that  the  sensi-
ivity  of  99mTc-sestamibi  SPECT/CT  was  signiﬁcantly  higher
han  that  of  planar  parathyroid  scintigraphy,  due  to  its  supe-
ior  resolution  compared  to  static  planar  scintigraphy  [10].
n  the  other  hand,  previous  study  suggested  that  both  early
nd  delayed  phase  99mTc-sestamibi  SPECT/CT  should  be
erformed  in  the  preoperative  evaluation  of  hemodialysis
atients  with  SHPT,  without  increasing  the  radiation  dose
ompared  with  the  use  of  only  the  early  or  the  delayed  phase
9]. In  the  present  study,  136/163  parathyroid  glands  were
ositive  in  early  phase  of  99mTc-MIBI  SPECT/CT  scan,  while
42/163  parathyroid  glands  were  positive  in  delayed  phase.
Another  ﬁnding  of  the  present  study  is  that  12  ectopic
arathyroid  were  demonstrated  by  99mTc-sestamibi
arathyroid  SPECT/CT  scintigraphy.  However,  ultrasound
emonstrated  only  2  intra-thyroid  ectopic  PTGs.  The  other
ctopic  PTGs  was  not  demonstrated  on  ultrasound  images.
t  means  that  ultrasound  failed  to  detect  PTG  localized
n  atypical  sites,  such  as  anterior  or  middle  mediastinum,
etro-esophageal  region.  Vulpio  et  al.  also  reported  that
ltrasound  globally  detected  57/99  PTGs  in  patients  with
HPT.  However,  only  one  of  15  ectopic  PTGs  was  detected
y  ultrasound.  It  means  that  the  sensitivity  of  ultrasound
n  detecting  the  ectopic  PTGs  was  low  [18].  On  the  other
and,  the  overall  risk  that  at  least  one  gland  be  ectopic  in
atients  with  SHPT  is  4  times  higher,  although  the  risk  of
ajor  ectopy  is  about  2%—3%  in  primary  HPT  [21].  Ishibashi
t  al.  also  reported  that  the  99mTc-sestamibi  scintigraphy  is
he  only  diagnostic  method  that  can  identify  ectopic  glands
n  patients  with  SHPT  [22]. The  scan  range  of  SPECT  in  the
resent  study  included  the  neck  and  thorax  with  an  axial
eld  of  view  of  53.3  ×  38.7  cm  because  ectopic  glands  may
e  widely  distributed  along  the  parathyroid  cell  migration
outes  [30].  Detection  of  ectopic  parathyroid  glands  is
robably  the  most  important  value  of  preoperative  imaging
n  patients  with  SHPT.  Previous  study  reported  that  the
igh  sensitivity  to  visualize  ectopic  parathyroid  glands  was
onsidered  the  main  advantage  of  scintigraphy  compared
ith  ultrasound  [6].
Another  advantage  of  SPECT/CT  is  the  accurate  and
natomic  depiction  of  the  PTG  location,  size,  and  adjacent
issues  or  structure,  which  facilitates  the  operative  plan-
ing.  Hybrid  SPECT/CT  systems  that  combine  conventional
T  with  SPECT  have  been  available  for  clinical  application
n  recent  years.  SPECT/CT  has  shown  to  be  more  speciﬁc
nd  sensitive  in  detecting  and  interpreting  small  PTGs.  This
s  due  to  the  combination  of  precise  anatomical  detail
vailable  with  high  spatial  resolution  CT  and  metabolism
r  functional  information  through  SPECT  [31,32]. In  the
resent  study,  SPECT/CT  was  able  to  accurately  localize
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nd  characterize  the  12  ectopic  parathyroid.  Therefore,
e  suggested  the  combined  application  of  ultrasound  and
9mTc-SPECT/CT  was  performed  for  the  preoperative  loca-
ion  of  parathyroid  tissue  in  patients  with  SHPT.
imitation
he  ﬁrst  limitation  is  that  the  dual  phase  99mTc-MIBI
arathyroid  SPECT/CT  scintigraphy  was  used  in  this  study.
revious  studies  reported  that  simultaneous  dual-isotope
maging,  with  99mTc-MIBI  + 123I,  was  superior  to  that  of  single
racer  technique  in  primary  hyperparathyroidism  [33,34].
he  second  limitation  is  that  the  diagnostic  indexes  of
9mTc-sestamibi  parathyroid  SPECT/CT  were  not  compared
ith  the  PTH  levels.  Previous  study  reported  that  overall
ensitivity  of  parathyroid  scintigraphy  depending  on  serum
TH  levels  in  hyperparathyroidism  [35,36].  The  third  limita-
ion  is  that  we  did  not  follow  up  the  patient’s  outcomes,
uch  as  rate  of  recurrence  and  hypoparathyroidism.  We
ould  follow-up  these  patients  in  the  future.  The  fourth
imitation  is  that  patients  with  positive  99mTc-sestamibi
PECT/CT  or  ultrasound  result  would  perform  the  surgery,
hich  would  decrease  the  sensitivity  values  of  preoperative
maging  modalities.  On  the  other  hand,  some  new  radiotrac-
rs,  including 11C-methionine  PET  and 18F-choline  PET,  have
een  used  in  the  diagnosis  of  hyperparathyroidism  [37,38].
1C-methionine  PET  seems  to  be  a  sensitive  method  for
yperparathyroidism  patients  before  reoperation.
onclusions
ur  study  demonstrates  that  the  combined  application
f  ultrasound  and  99mTc-sestamibi  SPECT/CT  has  incre-
ental  value  in  accurately  detecting  parathyroid  tissue  in
atients  with  SHPT  over  either  method  alone.  Ultrasound
s  largely  used  in  clinical  practice  as  it  is  noninvasive,  eas-
ly  repeatable  and  has  acceptable  sensitivity  and  speciﬁcity.
PECT/CT  cannot  only  detect  more  PTGs,  but  also  more
ccurately  depicts  the  precise  location  of  PTGs.  At  the  same
ime,  dual  phase  SPECT/CT  did  not  add  the  radiation  dose
han  early  or  delayed  phase  SPECT/CT  scan.
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